Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC
- PMID: 19473531
- PMCID: PMC2693114
- DOI: 10.1186/1476-4598-8-29
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC
Abstract
Background: This study aimed to investigate squamous cellular carcinoma antigen (SCCA) in serum and in tumoral and paired peritumoral tissues. We studied 27 patients with liver cirrhosis (LC) and 55 with HCC: 20 with a single nodule < 3 cm (s-HCC) and 35 with a single nodule > 3 cm or multifocal (l-HCC).
Methods: Serum SCCA was measured by the ELISA kit, and in frozen tissues by immunohistochemistry, quantified with appropriate imaging analysis software and expressed in square microns. Continuous variables are reported as means and 95% confidence intervals. Comparisons between independent groups were performed with a generalized linear model and Tukey grouping. Pearson's correlation coefficients were determined to evaluate relations between markers. Qualitative variables were summarized as count and percentage. Statistical significance was set at p-value < 0.05.
Results: Serum SCCA values in LC patients were 0.41 (0.31-0.55) ng/ml and statistically different from both HCC groups: 1.6 (1.0-2.6) ng/ml in s-HCC, 2.2 (1.28-2.74) ng/ml in l-HCC. SCCA in hepatic tissue was 263.8 (176.6-394.01) microm2 in LC patients, statistically different from values in s-HCC: 1163.2 (863.6-1566.8) microm2 and l-HCC: 625.8 (534.5-732.6). All pairwise comparisons between groups yielded statistically significant differences. Tumoral SCCA resulted linearly related with nodule size, showing a statistically significant inverse relation between the two variables (b = -0.099, p = 0.024).
Conclusion: There was no statistically significant correlation between tissue and serum levels of SCCA. The significantly stronger expression of SCCA in smaller compared to larger HCC could be important for early HCC detection. However, the increased expression in peritumoral tissue could affect the significance of serological detection.
Figures




Similar articles
-
Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.Tumour Biol. 2014 Nov;35(11):11559-64. doi: 10.1007/s13277-014-2467-y. Epub 2014 Aug 17. Tumour Biol. 2014. PMID: 25129443
-
Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.Indian J Cancer. 2008 Oct-Dec;45(4):167-72. doi: 10.4103/0019-509x.44666. Indian J Cancer. 2008. PMID: 19112206
-
Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.Scand J Clin Lab Invest. 2017 Oct;77(6):448-453. doi: 10.1080/00365513.2017.1336569. Epub 2017 Jun 13. Scand J Clin Lab Invest. 2017. PMID: 28609160
-
Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?Clin Chim Acta. 2015 May 20;445:161-6. doi: 10.1016/j.cca.2015.03.031. Epub 2015 Apr 1. Clin Chim Acta. 2015. PMID: 25840050 Review.
-
Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.Minerva Med. 2011 Oct;102(5):363-71. Minerva Med. 2011. PMID: 22193346 Review.
Cited by
-
Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors.EMBO Rep. 2022 Jun 7;23(6):e54275. doi: 10.15252/embr.202154275. Epub 2022 Apr 19. EMBO Rep. 2022. PMID: 35437924 Free PMC article.
-
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.Br J Cancer. 2014 May 27;110(11):2708-15. doi: 10.1038/bjc.2014.246. Epub 2014 May 8. Br J Cancer. 2014. PMID: 24809782 Free PMC article.
-
Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.J Mol Histol. 2015 Feb;46(1):79-91. doi: 10.1007/s10735-014-9602-3. Epub 2014 Dec 2. J Mol Histol. 2015. PMID: 25447507
-
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.Liver Int. 2022 Jan;42(1):233-248. doi: 10.1111/liv.15049. Epub 2021 Sep 16. Liver Int. 2022. PMID: 34478594 Free PMC article.
-
Squamous Cell Carcinoma Antigen: Clinical Application and Research Status.Diagnostics (Basel). 2022 Apr 24;12(5):1065. doi: 10.3390/diagnostics12051065. Diagnostics (Basel). 2022. PMID: 35626221 Free PMC article. Review.
References
-
- Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001:421–430. doi: 10.1016/S0168-8278(01)00130-1. - DOI - PubMed
-
- Farinati F, Marino D, DE Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnu L, Zoli M, Borzio F, Bernardi M, Trevisani F. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol. 2006:524–532. doi: 10.1111/j.1572-0241.2006.00443.x. - DOI - PubMed
-
- Giannelli G, Fransvea E, Trerotoli P, Beaugrand M, Marinosci F, Lupo L, Nkontchou G, Dentico P, Antonaci S. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta. 2007:147–152. doi: 10.1016/j.cca.2007.05.014. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials